Royalty Pharma plc (RPRX)

Nasdaq: RPRX · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2020

Grade6.3

◀ Past 6.5● Present 7.2▶ Future 5.0

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Report filed	Feb 11, 2026	Feb 12, 2025	Feb 15, 2024	Feb 15, 2023	Feb 15, 2022	Feb 24, 2021	·	·
Revenue	2,378,193	2,263,576	2,354,554	2,237,215	2,289,463	2,122,353	1,814,254	1,794,894
For lenders
Provision for credit losses	26,163	-100,415^r	-22,285^r	-193,798	-12,913	156,186	-1,019,321	-57,334
Research and development	452,000	2,000	52,000	177,106	200,084	26,289	83,036	392,609
General and administrative	573,481	236,671	249,748	227,303	182,826	181,715	103,439	61,906
Total costs and expenses	818,675	971,132	862,404	1,930,150	858,748	526,954	-808,922	430,448
Operating income	1,559,518	1,292,444	1,492,150	307,065	1,430,715	1,595,399	2,623,176	1,364,446
Interest expense	307,664	225,512	187,187	187,961	166,142	157,059	268,573	279,956
Interest and investment income	33,591	47,343	72,291	78,335	53,535	28,379	22,329	24,441
Share of profit of equity-method investments	29,089	29,611	28,882	-8,973	-19,490	44,459	-32,517	-7,023
Other income (expense), net	-14,349	-1,528	-21,737	-14,755	-5,678	-32,821	393	-1,518
Total non-operating income (expense)	-235,326	38,369	207,938	-77,001	-189,514	106,555	-161,757	153,409
Income before income taxes	1,324,192	1,330,813	1,700,088	230,064	1,241,201	1,701,954	2,461,419	1,517,855
Income tax expense	0	0	0	0	0	0	0	0
Net income including non-controlling interests	1,324,192	1,330,813	1,700,088	230,064	1,241,201	1,701,954	2,461,419	1,517,855
Net income to non-controlling interests	553,245	471,830	565,254	187,232	621,473	726,914	112,884	140,126
Net income	770,947	858,983	1,134,834	42,832	619,728	975,040	2,348,535	1,377,729
Net income to common shareholders	770,947	858,983	1,134,834	42,832	619,728	495,198	·	·
Earnings per share, basic	1.79	1.92	2.54	0.10	1.49	1.32	·	·
Earnings per share, diluted	1.78	1.91	2.53	0.10	1.49	1.32	·	·
Weighted average shares, basic	429,801	448,185	447,601	437,963	414,794	375,444	·	·
Weighted average shares, diluted	564,455	594,108	602,900	437,972	414,802	375,455	·	·

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldus-gaap:Revenues

Provision for credit losses set aside for loans that may not be repaid

us-gaap:ProvisionForLoanLossesExpensed
us-gaap:ProvisionForLoanAndLeaseLosses

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earned

us-gaap:InterestIncomeOther
us-gaap:InvestmentIncomeNet

Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton RPRX · research, not advice